Closing Arguments for Actos Lawsuit Trial Heard in L.A. Court, Manufacturer Maintains Defense of Diabetes Drug
Allegations that a popular diabetes drug may cause bladder cancer and other side effects continued to be denied by the manufacturer this week in closing arguments heard in the first trial for an Actos lawsuit in the U.S., Bloomberg.com reports.
On April 16th, 2013, a lawyer for Takeda Pharmaceuticals dismissed claims brought by the plaintiff in this case who says he developed bladder cancer after long-term use of Actos by highlighting the fact that he was a diabetic and former smoker. “The evidence is not only clear, it is overwhelming, that Mr. Cooper is in the highest-risk groups, and that his bladder cancer had nothing to do with Actos.”
Actos Lawyers State Closing Arguments in Los Angeles State Court
An Actos lawyer for the plaintiff countered this defense in Los Angeles state court by pointing out that Takeda did not alert U.S. health regulators about an internal study it conducted in 2004 that revealed a link between bladder cancer and use of the drug. The attorney said the company did not disclose this information to the public for seven years to prevent billion-dollar losses in sales of the drug.
The trial for this Actos lawsuit, which began February 19th, 2013 in Los Angeles state court, is the first of 3,000 to do so over the diabetes medication marketed by Asia’s biggest drugmaker, Takeda Pharmaceuticals.
Included in the claims brought by the plaintiff, a retired cable splicer who took Actos for two years before becoming “gravely ill” from the bladder cancer he was diagnosed with in November 2011 is the allegation that Takeda failed to warn about the potential for Actos to cause or worsen the disease. According to the Bloomberg.com article, jurors ended deliberations April 16 about whether Takeda should be held liable for these charges.
“Selling diabetes drugs is big business in America,” the plaintiff’s attorney said in his closing arguments. “There’s a lot of money to be made. But companies are not allowed to downplay the risk. Patient safety is the No. 1 thing.”
The panel in Los Angeles state court will continue to consider the case on April 17. Of the 3,000 Actos cases filed in the U.S., approximately 1,200 are pending in a federal litigation currently underway in the U.S. District Court for the Western District of Louisiana.
How to File an Actos Lawsuit
If you were diagnosed with bladder cancer after taking Actos, you may be eligible to file a claim against the manufacturer. Actos lawsuits seek compensation for medical expenses, lost wages and other expenses. Contact an attorney at Bernstein Liebhard LLP today by calling (877) 779-1414.